"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","characteristics_ch1.8","characteristics_ch1.9","characteristics_ch1.10","characteristics_ch1.11","characteristics_ch1.12","characteristics_ch1.13","characteristics_ch1.14","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","Age:ch1","Annotation:ch1","Cohort:ch1","EGFR status:ch1","Evidence of relapse:ch1","Histology:ch1","K-ras Status:ch1","p53 Status:ch1","Sex:ch1","Site of relapse:ch1","Smoking (BI):ch1","Stage (Pathological ):ch1","Status:ch1","Survival (days):ch1","TNM (Pathological):ch1"
"GSM333673","Patient 001 with adenocarcinoma","GSM333673","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD001","Cohort: dataset I","Age: 71","Sex: M","Histology: AD","Smoking (BI): 1020","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1326","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333673/suppl/GSM333673.txt.gz","41000","71","AD001","dataset I","Mut","Y","AD","Wt","Wt","M","PM","1020","IB","Dead","1326","T2N0M0"
"GSM333674","Patient 002 with adenocarcinoma","GSM333674","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD002","Cohort: dataset I","Age: 49","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 3275","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333674/suppl/GSM333674.txt.gz","41000","49","AD002","dataset I","Wt","N","AD","Wt","Wt","F","","0","IA","Alive","3275","T1N0M0"
"GSM333675","Patient 003 with adenocarcinoma","GSM333675","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD003","Cohort: dataset I","Age: 51","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 1687","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333675/suppl/GSM333675.txt.gz","41000","51","AD003","dataset I","Wt","Y","AD","Wt","Mut","F","PM","0","IIIA","Dead","1687","T2N2M0"
"GSM333676","Patient 004 with adenocarcinoma","GSM333676","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD004","Cohort: dataset I","Age: 51","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N1M0","Stage (Pathological ): IIA","Status: Alive","Survival (days): 3214","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333676/suppl/GSM333676.txt.gz","41000","51","AD004","dataset I","Wt","N","AD","Wt","Wt","F","","0","IIA","Alive","3214","T1N1M0"
"GSM333677","Patient 005 with adenocarcinoma","GSM333677","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD005","Cohort: dataset I","Age: 67","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 1200","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333677/suppl/GSM333677.txt.gz","41000","67","AD005","dataset I","Mut","Y","AD","Wt","Mut","F","PM","0","IIIA","Dead","1200","T1N2M0"
"GSM333678","Patient 006 with adenocarcinoma","GSM333678","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD006","Cohort: dataset I","Age: 66","Sex: M","Histology: AD","Smoking (BI): 100","TNM (Pathological): T3N1M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 223","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333678/suppl/GSM333678.txt.gz","41000","66","AD006","dataset I","Mut","Y","AD","Wt","Wt","M","Brain","100","IIIA","Dead","223","T3N1M0"
"GSM333679","Patient 007 with adenocarcinoma","GSM333679","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD007","Cohort: dataset I","Age: 71","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 3245","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333679/suppl/GSM333679.txt.gz","41000","71","AD007","dataset I","Mut","N","AD","Wt","Wt","F","","0","IA","Alive","3245","T1N0M0"
"GSM333680","Patient 008 with adenocarcinoma","GSM333680","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD008","Cohort: dataset I","Age: 62","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T4N0M0","Stage (Pathological ): IIIB","Status: Alive","Survival (days): 3274","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333680/suppl/GSM333680.txt.gz","41000","62","AD008","dataset I","Wt","N","AD","Mut","Wt","F","","0","IIIB","Alive","3274","T4N0M0"
"GSM333681","Patient 009 with adenocarcinoma","GSM333681","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD009","Cohort: dataset I","Age: 47","Sex: F","Histology: AD","Smoking (BI): 120","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 511","Evidence of relapse: Y","Site of relapse: Liver, adrenal","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333681/suppl/GSM333681.txt.gz","41000","47","AD009","dataset I","Mut","Y","AD","Wt","Wt","F","Liver, adrenal","120","IIIA","Dead","511","T2N2M0"
"GSM333682","Patient 010 with adenocarcinoma","GSM333682","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD010","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 150","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 3245","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333682/suppl/GSM333682.txt.gz","41000","60","AD010","dataset I","Wt","N","AD","Wt","Wt","F","","150","IA","Alive","3245","T1N0M0"
"GSM333683","Patient 011 with adenocarcinoma","GSM333683","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD011","Cohort: dataset I","Age: 64","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 3295","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333683/suppl/GSM333683.txt.gz","41000","64","AD011","dataset I","Mut","Y","AD","Wt","Wt","F","PM","0","IB","Alive","3295","T2N0M0"
"GSM333684","Patient 012 with adenocarcinoma","GSM333684","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD012","Cohort: dataset I","Age: 57","Sex: M","Histology: AD","Smoking (BI): 1110","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 3260","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333684/suppl/GSM333684.txt.gz","41000","57","AD012","dataset I","Mut","N","AD","Wt","Mut","M","","1110","IIIA","Alive","3260","T2N2M0"
"GSM333685","Patient 013 with adenocarcinoma","GSM333685","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD013","Cohort: dataset I","Age: 55","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Dead","Survival (days): 1855","Evidence of relapse: Y","Site of relapse: Liver","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333685/suppl/GSM333685.txt.gz","41000","55","AD013","dataset I","Mut","Y","AD","Wt","Mut","F","Liver","0","IIB","Dead","1855","T3N0M0"
"GSM333686","Patient 014 with adenocarcinoma","GSM333686","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD014","Cohort: dataset I","Age: 74","Sex: M","Histology: AD","Smoking (BI): 810","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 694","Evidence of relapse: Y","Site of relapse: LN (mediastinal)","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333686/suppl/GSM333686.txt.gz","41000","74","AD014","dataset I","Wt","Y","AD","Mut","Wt","M","LN (mediastinal)","810","IIIA","Dead","694","T1N2M0"
"GSM333687","Patient 015 with adenocarcinoma","GSM333687","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD015","Cohort: dataset I","Age: 61","Sex: M","Histology: AD","Smoking (BI): 1230","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 3246","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333687/suppl/GSM333687.txt.gz","41000","61","AD015","dataset I","Wt","N","AD","Wt","Wt","M","","1230","IA","Alive","3246","T1N0M0"
"GSM333688","Patient 016 with adenocarcinoma","GSM333688","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD016","Cohort: dataset I","Age: 67","Sex: F","Histology: AD","Smoking (BI): 200","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 3169","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333688/suppl/GSM333688.txt.gz","41000","67","AD016","dataset I","Wt","N","AD","Wt","Mut","F","","200","IB","Alive","3169","T2N0M0"
"GSM333689","Patient 018 with adenocarcinoma","GSM333689","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD018","Cohort: dataset I","Age: 59","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1030","Evidence of relapse: Y","Site of relapse: Local rec.","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333689/suppl/GSM333689.txt.gz","41000","59","AD018","dataset I","Wt","Y","AD","Wt","Wt","M","Local rec.","0","IB","Dead","1030","T2N0M0"
"GSM333690","Patient 019 with adenocarcinoma","GSM333690","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD019","Cohort: dataset I","Age: 66","Sex: M","Histology: AD","Smoking (BI): 1040","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 2102","Evidence of relapse: Y","Site of relapse: LN (mediastinal)","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333690/suppl/GSM333690.txt.gz","41000","66","AD019","dataset I","Wt","Y","AD","Wt","Wt","M","LN (mediastinal)","1040","IIIA","Dead","2102","T1N2M0"
"GSM333691","Patient 020 with adenocarcinoma","GSM333691","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD020","Cohort: dataset I","Age: 68","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 3057","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333691/suppl/GSM333691.txt.gz","41000","68","AD020","dataset I","Wt","N","AD","Wt","Wt","F","","0","IIIA","Alive","3057","T2N2M0"
"GSM333692","Patient 021 with adenocarcinoma","GSM333692","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD021","Cohort: dataset I","Age: 64","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 3182","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333692/suppl/GSM333692.txt.gz","41000","64","AD021","dataset I","Wt","N","AD","Wt","Mut","M","","0","IA","Alive","3182","T1N0M0"
"GSM333693","Patient 023 with adenocarcinoma","GSM333693","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD023","Cohort: dataset I","Age: 43","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 3004","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333693/suppl/GSM333693.txt.gz","41000","43","AD023","dataset I","Wt","N","AD","Wt","Wt","M","","0","IB","Alive","3004","T2N0M0"
"GSM333694","Patient 024 with adenocarcinoma","GSM333694","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD024","Cohort: dataset I","Age: 73","Sex: M","Histology: AD","Smoking (BI): 430","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 3170","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333694/suppl/GSM333694.txt.gz","41000","73","AD024","dataset I","Wt","N","AD","Wt","Wt","M","","430","IIIA","Alive","3170","T1N2M0"
"GSM333695","Patient 025 with adenocarcinoma","GSM333695","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD025","Cohort: dataset I","Age: 72","Sex: M","Histology: AD","Smoking (BI): 636","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2974","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333695/suppl/GSM333695.txt.gz","41000","72","AD025","dataset I","Wt","N","AD","Wt","Mut","M","","636","IB","Alive","2974","T2N0M0"
"GSM333696","Patient 026 with adenocarcinoma","GSM333696","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD026","Cohort: dataset I","Age: 56","Sex: M","Histology: AD","Smoking (BI): 1200","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2879","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333696/suppl/GSM333696.txt.gz","41000","56","AD026","dataset I","Mut","N","AD","Wt","Wt","M","","1200","IA","Alive","2879","T1N0M0"
"GSM333697","Patient 027 with adenocarcinoma","GSM333697","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD027","Cohort: dataset I","Age: 75","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Dead","Survival (days): 1271","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333697/suppl/GSM333697.txt.gz","41000","75","AD027","dataset I","Mut","Y","AD","Wt","Wt","M","PM","0","IIB","Dead","1271","T3N0M0"
"GSM333698","Patient 029 with adenocarcinoma","GSM333698","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD029","Cohort: dataset I","Age: 62","Sex: M","Histology: AD","Smoking (BI): 1600","TNM (Pathological): T2N1M0","Stage (Pathological ): IIB","Status: Alive","Survival (days): 2979","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333698/suppl/GSM333698.txt.gz","41000","62","AD029","dataset I","Wt","N","AD","Wt","Mut","M","","1600","IIB","Alive","2979","T2N1M0"
"GSM333699","Patient 030 with adenocarcinoma","GSM333699","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD030","Cohort: dataset I","Age: 61","Sex: M","Histology: AD","Smoking (BI): 1140","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2905","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333699/suppl/GSM333699.txt.gz","41000","61","AD030","dataset I","Wt","N","AD","Mut","Wt","M","","1140","IB","Alive","2905","T2N0M0"
"GSM333700","Patient 031 with adenocarcinoma","GSM333700","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD031","Cohort: dataset I","Age: 32","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T4N2M0","Stage (Pathological ): IIIB","Status: Dead","Survival (days): 2885","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333700/suppl/GSM333700.txt.gz","41000","32","AD031","dataset I","Wt","Y","AD","Wt","Wt","F","PM","0","IIIB","Dead","2885","T4N2M0"
"GSM333701","Patient 032 with adenocarcinoma","GSM333701","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD032","Cohort: dataset I","Age: 53","Sex: M","Histology: AD","Smoking (BI): 1980","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2701","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333701/suppl/GSM333701.txt.gz","41000","53","AD032","dataset I","Wt","Y","AD","Wt","Wt","M","Bone","1980","IA","Alive","2701","T1N0M0"
"GSM333702","Patient 033 with adenocarcinoma","GSM333702","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD033","Cohort: dataset I","Age: 66","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T4N0M0","Stage (Pathological ): IIIB","Status: Dead","Survival (days): 896","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333702/suppl/GSM333702.txt.gz","41000","66","AD033","dataset I","Wt","Y","AD","Mut","Wt","M","PM","0","IIIB","Dead","896","T4N0M0"
"GSM333703","Patient 034 with adenocarcinoma","GSM333703","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD034","Cohort: dataset I","Age: 55","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T3N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 2910","Evidence of relapse: Y","Site of relapse: LN (neck)","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333703/suppl/GSM333703.txt.gz","41000","55","AD034","dataset I","Wt","Y","AD","Wt","Mut","F","LN (neck)","0","IIIA","Alive","2910","T3N2M0"
"GSM333704","Patient 035 with adenocarcinoma","GSM333704","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD035","Cohort: dataset I","Age: 62","Sex: M","Histology: AD","Smoking (BI): 400","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Alive","Survival (days): 2813","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333704/suppl/GSM333704.txt.gz","41000","62","AD035","dataset I","Wt","N","AD","Wt","Wt","M","","400","IIB","Alive","2813","T3N0M0"
"GSM333705","Patient 036 with adenocarcinoma","GSM333705","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD036","Cohort: dataset I","Age: 64","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2749","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333705/suppl/GSM333705.txt.gz","41000","64","AD036","dataset I","Mut","N","AD","Wt","Wt","F","","0","IB","Alive","2749","T2N0M0"
"GSM333706","Patient 037 with adenocarcinoma","GSM333706","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD037","Cohort: dataset I","Age: 63","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2932","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333706/suppl/GSM333706.txt.gz","41000","63","AD037","dataset I","Mut","Y","AD","Wt","Wt","F","PM","0","IA","Alive","2932","T1N0M0"
"GSM333707","Patient 038 with adenocarcinoma","GSM333707","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD038","Cohort: dataset I","Age: 69","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1389","Evidence of relapse: Y","Site of relapse: Local rec.","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333707/suppl/GSM333707.txt.gz","41000","69","AD038","dataset I","Mut","Y","AD","Wt","Wt","F","Local rec.","0","IB","Dead","1389","T2N0M0"
"GSM333708","Patient 039 with adenocarcinoma","GSM333708","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD039","Cohort: dataset I","Age: 52","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2796","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333708/suppl/GSM333708.txt.gz","41000","52","AD039","dataset I","Mut","N","AD","Wt","Wt","F","","0","IB","Alive","2796","T2N0M0"
"GSM333709","Patient 040 with adenocarcinoma","GSM333709","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD040","Cohort: dataset I","Age: 52","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 361","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333709/suppl/GSM333709.txt.gz","41000","52","AD040","dataset I","Mut","Y","AD","Wt","Wt","F","Bone","0","IIIA","Dead","361","T2N2M0"
"GSM333710","Patient 041 with adenocarcinoma","GSM333710","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD041","Cohort: dataset I","Age: 62","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 397","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333710/suppl/GSM333710.txt.gz","41000","62","AD041","dataset I","Mut","Y","AD","Wt","Mut","M","PM","0","IIIA","Dead","397","T2N2M0"
"GSM333711","Patient 042 with adenocarcinoma","GSM333711","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD042","Cohort: dataset I","Age: 62","Sex: M","Histology: AD","Smoking (BI): 840","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2506","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333711/suppl/GSM333711.txt.gz","41000","62","AD042","dataset I","Wt","N","AD","Wt","Wt","M","","840","IA","Alive","2506","T1N0M0"
"GSM333712","Patient 043 with adenocarcinoma","GSM333712","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD043","Cohort: dataset I","Age: 67","Sex: M","Histology: AD","Smoking (BI): 820","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2426","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333712/suppl/GSM333712.txt.gz","41000","67","AD043","dataset I","Wt","N","AD","Wt","Wt","M","","820","IB","Alive","2426","T2N0M0"
"GSM333713","Patient 044 with adenocarcinoma","GSM333713","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD044","Cohort: dataset I","Age: 63","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 2193","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333713/suppl/GSM333713.txt.gz","41000","63","AD044","dataset I","Wt","Y","AD","Wt","Wt","F","PM","0","IIIA","Dead","2193","T1N2M0"
"GSM333714","Patient 045 with adenocarcinoma","GSM333714","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD045","Cohort: dataset I","Age: 49","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2797","Evidence of relapse: Y","Site of relapse: Adrenal","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333714/suppl/GSM333714.txt.gz","41000","49","AD045","dataset I","Mut","Y","AD","Wt","Wt","F","Adrenal","0","IB","Alive","2797","T2N0M0"
"GSM333715","Patient 046 with adenocarcinoma","GSM333715","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD046","Cohort: dataset I","Age: 59","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N1M0","Stage (Pathological ): IIB","Status: Alive","Survival (days): 2355","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333715/suppl/GSM333715.txt.gz","41000","59","AD046","dataset I","Mut","Y","AD","Wt","Wt","F","Bone","0","IIB","Alive","2355","T2N1M0"
"GSM333716","Patient 047 with adenocarcinoma","GSM333716","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD047","Cohort: dataset I","Age: 46","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N1M0","Stage (Pathological ): IIA","Status: Alive","Survival (days): 2729","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333716/suppl/GSM333716.txt.gz","41000","46","AD047","dataset I","Mut","N","AD","Wt","Mut","M","","0","IIA","Alive","2729","T1N1M0"
"GSM333717","Patient 048 with adenocarcinoma","GSM333717","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD048","Cohort: dataset I","Age: 61","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2702","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333717/suppl/GSM333717.txt.gz","41000","61","AD048","dataset I","Mut","N","AD","Wt","Mut","F","","0","IA","Alive","2702","T1N0M0"
"GSM333718","Patient 049 with adenocarcinoma","GSM333718","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD049","Cohort: dataset I","Age: 35","Sex: F","Histology: AD","Smoking (BI): 20","TNM (Pathological): T4N2M0","Stage (Pathological ): IIIB","Status: Dead","Survival (days): 636","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333718/suppl/GSM333718.txt.gz","41000","35","AD049","dataset I","Wt","Y","AD","Wt","Wt","F","Brain","20","IIIB","Dead","636","T4N2M0"
"GSM333719","Patient 050 with adenocarcinoma","GSM333719","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD050","Cohort: dataset I","Age: 76","Sex: M","Histology: AD","Smoking (BI): 1620","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 828","Evidence of relapse: Unknown","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333719/suppl/GSM333719.txt.gz","41000","76","AD050","dataset I","Wt","Unknown","AD","Mut","Wt","M","","1620","IB","Dead","828","T2N0M0"
"GSM333720","Patient 051 with adenocarcinoma","GSM333720","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD051","Cohort: dataset I","Age: 76","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2702","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333720/suppl/GSM333720.txt.gz","41000","76","AD051","dataset I","Wt","N","AD","Wt","Mut","F","","0","IB","Alive","2702","T2N0M0"
"GSM333721","Patient 052 with adenocarcinoma","GSM333721","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD052","Cohort: dataset I","Age: 84","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2456","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333721/suppl/GSM333721.txt.gz","41000","84","AD052","dataset I","Wt","N","AD","Wt","Wt","F","","0","IB","Alive","2456","T2N0M0"
"GSM333722","Patient 053 with adenocarcinoma","GSM333722","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD053","Cohort: dataset I","Age: 64","Sex: M","Histology: AD","Smoking (BI): 1540","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 784","Evidence of relapse: Y","Site of relapse: LN (neck)","EGFR status: Wt","K-ras Status: Mut","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333722/suppl/GSM333722.txt.gz","41000","64","AD053","dataset I","Wt","Y","AD","Mut","Mut","M","LN (neck)","1540","IIIA","Dead","784","T2N2M0"
"GSM333723","Patient 054 with adenocarcinoma","GSM333723","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD054","Cohort: dataset I","Age: 53","Sex: F","Histology: AD","Smoking (BI): 835","TNM (Pathological): T4N2M0","Stage (Pathological ): IIIB","Status: Dead","Survival (days): 596","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333723/suppl/GSM333723.txt.gz","41000","53","AD054","dataset I","Wt","N","AD","Wt","Wt","F","","835","IIIB","Dead","596","T4N2M0"
"GSM333724","Patient 055 with adenocarcinoma","GSM333724","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD055","Cohort: dataset I","Age: 53","Sex: F","Histology: AD","Smoking (BI): 120","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 2520","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333724/suppl/GSM333724.txt.gz","41000","53","AD055","dataset I","Mut","N","AD","Wt","Mut","F","","120","IIIA","Alive","2520","T1N2M0"
"GSM333725","Patient 056 with adenocarcinoma","GSM333725","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD056","Cohort: dataset I","Age: 62","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 2347","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333725/suppl/GSM333725.txt.gz","41000","62","AD056","dataset I","Wt","Y","AD","Wt","Wt","F","PM","0","IB","Dead","2347","T2N0M0"
"GSM333726","Patient 057 with adenocarcinoma","GSM333726","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD057","Cohort: dataset I","Age: 73","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1880","Evidence of relapse: Y","Site of relapse: Local rec.","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333726/suppl/GSM333726.txt.gz","41000","73","AD057","dataset I","Mut","Y","AD","Wt","Wt","F","Local rec.","0","IB","Dead","1880","T2N0M0"
"GSM333727","Patient 058 with adenocarcinoma","GSM333727","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD058","Cohort: dataset I","Age: 47","Sex: M","Histology: AD","Smoking (BI): 800","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 2050","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Wt","K-ras Status: Mut","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333727/suppl/GSM333727.txt.gz","41000","47","AD058","dataset I","Wt","Y","AD","Mut","Mut","M","Brain","800","IA","Dead","2050","T1N0M0"
"GSM333728","Patient 059 with adenocarcinoma","GSM333728","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD059","Cohort: dataset I","Age: 74","Sex: M","Histology: AD","Smoking (BI): 1060","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2072","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333728/suppl/GSM333728.txt.gz","41000","74","AD059","dataset I","Wt","N","AD","Wt","Wt","M","","1060","IB","Alive","2072","T2N0M0"
"GSM333729","Patient 060 with adenocarcinoma","GSM333729","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD060","Cohort: dataset I","Age: 56","Sex: M","Histology: AD","Smoking (BI): 1260","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 440","Evidence of relapse: Y","Site of relapse: LN (neck)","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333729/suppl/GSM333729.txt.gz","41000","56","AD060","dataset I","Wt","Y","AD","Wt","Mut","M","LN (neck)","1260","IB","Dead","440","T2N0M0"
"GSM333730","Patient 061 with adenocarcinoma","GSM333730","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD061","Cohort: dataset I","Age: 69","Sex: M","Histology: AD","Smoking (BI): 675","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2525","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333730/suppl/GSM333730.txt.gz","41000","69","AD061","dataset I","Wt","N","AD","Wt","Wt","M","","675","IA","Alive","2525","T1N0M0"
"GSM333731","Patient 062 with adenocarcinoma","GSM333731","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD062","Cohort: dataset I","Age: 68","Sex: M","Histology: AD","Smoking (BI): 570","TNM (Pathological): T1N1M0","Stage (Pathological ): IIA","Status: Dead","Survival (days): 482","Evidence of relapse: Y","Site of relapse: Liver","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333731/suppl/GSM333731.txt.gz","41000","68","AD062","dataset I","Wt","Y","AD","Wt","Wt","M","Liver","570","IIA","Dead","482","T1N1M0"
"GSM333732","Patient 063 with adenocarcinoma","GSM333732","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD063","Cohort: dataset I","Age: 41","Sex: M","Histology: AD","Smoking (BI): 60","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1164","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333732/suppl/GSM333732.txt.gz","41000","41","AD063","dataset I","Mut","Y","AD","Wt","Mut","M","PM","60","IA","Dead","1164","T1N0M0"
"GSM333733","Patient 064 with adenocarcinoma","GSM333733","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD064","Cohort: dataset I","Age: 55","Sex: M","Histology: AD","Smoking (BI): 1440","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2533","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333733/suppl/GSM333733.txt.gz","41000","55","AD064","dataset I","Wt","N","AD","Wt","Wt","M","","1440","IA","Alive","2533","T1N0M0"
"GSM333734","Patient 065 with adenocarcinoma","GSM333734","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD065","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2528","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333734/suppl/GSM333734.txt.gz","41000","60","AD065","dataset I","Wt","N","AD","Wt","Mut","F","","0","IA","Alive","2528","T1N0M0"
"GSM333735","Patient 066 with adenocarcinoma","GSM333735","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD066","Cohort: dataset I","Age: 66","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2353","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333735/suppl/GSM333735.txt.gz","41000","66","AD066","dataset I","Mut","N","AD","Wt","Wt","M","","0","IA","Alive","2353","T1N0M0"
"GSM333736","Patient 067 with adenocarcinoma","GSM333736","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD067","Cohort: dataset I","Age: 42","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2507","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333736/suppl/GSM333736.txt.gz","41000","42","AD067","dataset I","Wt","N","AD","Wt","Wt","F","","0","IA","Alive","2507","T1N0M0"
"GSM333737","Patient 068 with adenocarcinoma","GSM333737","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD068","Cohort: dataset I","Age: 56","Sex: M","Histology: AD","Smoking (BI): 720","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Alive","Survival (days): 2519","Evidence of relapse: Y","Site of relapse: PM?bone","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333737/suppl/GSM333737.txt.gz","41000","56","AD068","dataset I","Mut","Y","AD","Wt","Wt","M","PM?bone","720","IIB","Alive","2519","T3N0M0"
"GSM333738","Patient 069 with adenocarcinoma","GSM333738","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD069","Cohort: dataset I","Age: 50","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2521","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333738/suppl/GSM333738.txt.gz","41000","50","AD069","dataset I","Mut","Y","AD","Wt","Mut","F","PM","0","IA","Alive","2521","T1N0M0"
"GSM333739","Patient 070 with adenocarcinoma","GSM333739","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD070","Cohort: dataset I","Age: 70","Sex: F","Histology: AD","Smoking (BI): 400","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 1501","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333739/suppl/GSM333739.txt.gz","41000","70","AD070","dataset I","Mut","Y","AD","Wt","Mut","F","Bone","400","IIIA","Dead","1501","T1N2M0"
"GSM333740","Patient 071 with adenocarcinoma","GSM333740","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD071","Cohort: dataset I","Age: 61","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2260","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333740/suppl/GSM333740.txt.gz","41000","61","AD071","dataset I","Wt","N","AD","Wt","Wt","M","","0","IA","Alive","2260","T1N0M0"
"GSM333741","Patient 072 with adenocarcinoma","GSM333741","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD072","Cohort: dataset I","Age: 63","Sex: M","Histology: AD","Smoking (BI): 900","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Alive","Survival (days): 2339","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333741/suppl/GSM333741.txt.gz","41000","63","AD072","dataset I","Wt","N","AD","Mut","Wt","M","","900","IIIA","Alive","2339","T2N2M0"
"GSM333742","Patient 073 with adenocarcinoma","GSM333742","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD073","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1229","Evidence of relapse: Y","Site of relapse: local rec","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333742/suppl/GSM333742.txt.gz","41000","60","AD073","dataset I","Wt","Y","AD","Wt","Wt","F","local rec","0","IB","Dead","1229","T2N0M0"
"GSM333743","Patient 074 with adenocarcinoma","GSM333743","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD074","Cohort: dataset I","Age: 58","Sex: M","Histology: AD","Smoking (BI): 690","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2341","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333743/suppl/GSM333743.txt.gz","41000","58","AD074","dataset I","Wt","N","AD","Mut","Wt","M","","690","IA","Alive","2341","T1N0M0"
"GSM333744","Patient 075 with adenocarcinoma","GSM333744","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD075","Cohort: dataset I","Age: 60","Sex: M","Histology: AD","Smoking (BI): 1200","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 777","Evidence of relapse: Y","Site of relapse: Local rec.","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333744/suppl/GSM333744.txt.gz","41000","60","AD075","dataset I","Wt","Y","AD","Wt","Mut","M","Local rec.","1200","IB","Dead","777","T2N0M0"
"GSM333745","Patient 076 with adenocarcinoma","GSM333745","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD076","Cohort: dataset I","Age: 65","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1333","Evidence of relapse: Y","Site of relapse: Local rec.,Brain","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333745/suppl/GSM333745.txt.gz","41000","65","AD076","dataset I","Wt","Y","AD","Wt","Mut","F","Local rec.,Brain","0","IA","Dead","1333","T1N0M0"
"GSM333746","Patient 077 with adenocarcinoma","GSM333746","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD077","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2348","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333746/suppl/GSM333746.txt.gz","41000","60","AD077","dataset I","Mut","N","AD","Wt","Mut","F","","0","IA","Alive","2348","T1N0M0"
"GSM333747","Patient 078 with adenocarcinoma","GSM333747","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD078","Cohort: dataset I","Age: 82","Sex: M","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1008","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333747/suppl/GSM333747.txt.gz","41000","82","AD078","dataset I","Wt","Y","AD","Wt","Wt","M","PM","0","IB","Dead","1008","T2N0M0"
"GSM333748","Patient 079 with adenocarcinoma","GSM333748","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD079","Cohort: dataset I","Age: 67","Sex: M","Histology: AD","Smoking (BI): 900","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Dead","Survival (days): 1201","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333748/suppl/GSM333748.txt.gz","41000","67","AD079","dataset I","Wt","Y","AD","Wt","Mut","M","Bone","900","IIB","Dead","1201","T3N0M0"
"GSM333749","Patient 080 with adenocarcinoma","GSM333749","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD080","Cohort: dataset I","Age: 67","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1956","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333749/suppl/GSM333749.txt.gz","41000","67","AD080","dataset I","Mut","N","AD","Wt","Mut","F","","0","IB","Alive","1956","T2N0M0"
"GSM333750","Patient 081 with adenocarcinoma","GSM333750","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD081","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 180","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 749","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333750/suppl/GSM333750.txt.gz","41000","60","AD081","dataset I","Mut","Y","AD","Wt","Wt","F","PM","180","IIIA","Dead","749","T2N2M0"
"GSM333751","Patient 082 with adenocarcinoma","GSM333751","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD082","Cohort: dataset I","Age: 66","Sex: M","Histology: AD","Smoking (BI): 800","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2335","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333751/suppl/GSM333751.txt.gz","41000","66","AD082","dataset I","Wt","N","AD","Wt","Wt","M","","800","IA","Alive","2335","T1N0M0"
"GSM333752","Patient 083 with adenocarcinoma","GSM333752","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD083","Cohort: dataset I","Age: 73","Sex: M","Histology: AD","Smoking (BI): 900","TNM (Pathological): T1N1M0","Stage (Pathological ): IIA","Status: Dead","Survival (days): 860","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333752/suppl/GSM333752.txt.gz","41000","73","AD083","dataset I","Mut","Y","AD","Wt","Wt","M","Brain","900","IIA","Dead","860","T1N1M0"
"GSM333753","Patient 084 with adenocarcinoma","GSM333753","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD084","Cohort: dataset I","Age: 74","Sex: M","Histology: AD","Smoking (BI): 1160","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 186","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333753/suppl/GSM333753.txt.gz","41000","74","AD084","dataset I","Wt","Y","AD","Mut","Wt","M","PM","1160","IB","Dead","186","T2N0M0"
"GSM333754","Patient 085 with adenocarcinoma","GSM333754","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD085","Cohort: dataset I","Age: 56","Sex: M","Histology: AD","Smoking (BI): 720","TNM (Pathological): T3N0M0","Stage (Pathological ): IIB","Status: Alive","Survival (days): 2342","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333754/suppl/GSM333754.txt.gz","41000","56","AD085","dataset I","Wt","N","AD","Wt","Wt","M","","720","IIB","Alive","2342","T3N0M0"
"GSM333755","Patient 086 with adenocarcinoma","GSM333755","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD086","Cohort: dataset I","Age: 49","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 1074","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333755/suppl/GSM333755.txt.gz","41000","49","AD086","dataset I","Mut","Y","AD","Wt","Wt","F","Brain","0","IIIA","Dead","1074","T1N2M0"
"GSM333756","Patient 087 with adenocarcinoma","GSM333756","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD087","Cohort: dataset I","Age: 60","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N1M0","Stage (Pathological ): IIB","Status: Dead","Survival (days): 867","Evidence of relapse: Y","Site of relapse: PM, Liver","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333756/suppl/GSM333756.txt.gz","41000","60","AD087","dataset I","Wt","Y","AD","Wt","Mut","F","PM, Liver","0","IIB","Dead","867","T2N1M0"
"GSM333757","Patient 088 with adenocarcinoma","GSM333757","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD088","Cohort: dataset I","Age: 53","Sex: M","Histology: AD","Smoking (BI): 1320","TNM (Pathological): T2N2M0","Stage (Pathological ): IIIA","Status: Dead","Survival (days): 304","Evidence of relapse: Y","Site of relapse: LN (neck)","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333757/suppl/GSM333757.txt.gz","41000","53","AD088","dataset I","Wt","Y","AD","Wt","Mut","M","LN (neck)","1320","IIIA","Dead","304","T2N2M0"
"GSM333758","Patient 089 with adenocarcinoma","GSM333758","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD089","Cohort: dataset I","Age: 51","Sex: M","Histology: AD","Smoking (BI): 56","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 906","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333758/suppl/GSM333758.txt.gz","41000","51","AD089","dataset I","Wt","Y","AD","Wt","Wt","M","Brain","56","IA","Dead","906","T1N0M0"
"GSM333759","Patient 090 with adenocarcinoma","GSM333759","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD090","Cohort: dataset I","Age: 74","Sex: M","Histology: AD","Smoking (BI): 800","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 477","Evidence of relapse: Y","Site of relapse: Local rec.","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset I","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333759/suppl/GSM333759.txt.gz","41000","74","AD090","dataset I","Wt","Y","AD","Wt","Wt","M","Local rec.","800","IA","Dead","477","T1N0M0"
"GSM333760","Patient 101 with adenocarcinoma","GSM333760","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD101","Cohort: dataset II","Age: 64","Sex: M","Histology: AD","Smoking (BI): 1480","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2294","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333760/suppl/GSM333760.txt.gz","41000","64","AD101","dataset II","Wt","N","AD","Mut","Wt","M","","1480","IB","Alive","2294","T2N0M0"
"GSM333761","Patient 102 with adenocarcinoma","GSM333761","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD102","Cohort: dataset II","Age: 49","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2288","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333761/suppl/GSM333761.txt.gz","41000","49","AD102","dataset II","Mut","N","AD","Wt","Wt","F","","0","IA","Alive","2288","T1N0M0"
"GSM333762","Patient 103 with adenocarcinoma","GSM333762","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD103","Cohort: dataset II","Age: 70","Sex: M","Histology: AD","Smoking (BI): 450","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2268","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333762/suppl/GSM333762.txt.gz","41000","70","AD103","dataset II","Mut","N","AD","Wt","Mut","M","","450","IB","Alive","2268","T2N0M0"
"GSM333763","Patient 104 with adenocarcinoma","GSM333763","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD104","Cohort: dataset II","Age: 75","Sex: M","Histology: AD","Smoking (BI): 2820","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2101","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333763/suppl/GSM333763.txt.gz","41000","75","AD104","dataset II","Wt","N","AD","Wt","Mut","M","","2820","IB","Alive","2101","T2N0M0"
"GSM333764","Patient 105 with adenocarcinoma","GSM333764","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD105","Cohort: dataset II","Age: 76","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2189","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333764/suppl/GSM333764.txt.gz","41000","76","AD105","dataset II","Wt","N","AD","Wt","Wt","F","","0","IA","Alive","2189","T1N0M0"
"GSM333765","Patient 106 with adenocarcinoma","GSM333765","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD106","Cohort: dataset II","Age: 53","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 2144","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333765/suppl/GSM333765.txt.gz","41000","53","AD106","dataset II","Mut","Y","AD","Wt","Mut","F","Brain","0","IA","Dead","2144","T1N0M0"
"GSM333766","Patient 107 with adenocarcinoma","GSM333766","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD107","Cohort: dataset II","Age: 75","Sex: M","Histology: AD","Smoking (BI): 900","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1920","Evidence of relapse: Y","Site of relapse: Bone","EGFR status: Wt","K-ras Status: Mut","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333766/suppl/GSM333766.txt.gz","41000","75","AD107","dataset II","Wt","Y","AD","Mut","Mut","M","Bone","900","IB","Dead","1920","T2N0M0"
"GSM333767","Patient 108 with adenocarcinoma","GSM333767","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD108","Cohort: dataset II","Age: 60","Sex: M","Histology: AD","Smoking (BI): 260","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2019","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333767/suppl/GSM333767.txt.gz","41000","60","AD108","dataset II","Mut","N","AD","Wt","Wt","M","","260","IA","Alive","2019","T1N0M0"
"GSM333768","Patient 109 with adenocarcinoma","GSM333768","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD109","Cohort: dataset II","Age: 61","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1213","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333768/suppl/GSM333768.txt.gz","41000","61","AD109","dataset II","Mut","Y","AD","Wt","Mut","F","PM","0","IA","Dead","1213","T1N0M0"
"GSM333769","Patient 110 with adenocarcinoma","GSM333769","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD110","Cohort: dataset II","Age: 67","Sex: M","Histology: AD","Smoking (BI): 2580","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1044","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333769/suppl/GSM333769.txt.gz","41000","67","AD110","dataset II","Wt","Y","AD","Wt","Wt","M","PM","2580","IA","Dead","1044","T1N0M0"
"GSM333770","Patient 111 with adenocarcinoma","GSM333770","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD111","Cohort: dataset II","Age: 63","Sex: M","Histology: AD","Smoking (BI): 2350","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1955","Evidence of relapse: Y","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333770/suppl/GSM333770.txt.gz","41000","63","AD111","dataset II","Wt","Y","AD","Mut","Wt","M","","2350","IB","Alive","1955","T2N0M0"
"GSM333771","Patient 112 with adenocarcinoma","GSM333771","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD112","Cohort: dataset II","Age: 56","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2067","Evidence of relapse: Y","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: N/A","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333771/suppl/GSM333771.txt.gz","41000","56","AD112","dataset II","Wt","Y","AD","Wt","N/A","F","","0","IA","Alive","2067","T1N0M0"
"GSM333772","Patient 113 with adenocarcinoma","GSM333772","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD113","Cohort: dataset II","Age: 69","Sex: F","Histology: AD","Smoking (BI): 180","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 2009","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333772/suppl/GSM333772.txt.gz","41000","69","AD113","dataset II","Wt","N","AD","Wt","Wt","F","","180","IB","Alive","2009","T2N0M0"
"GSM333773","Patient 114 with adenocarcinoma","GSM333773","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD114","Cohort: dataset II","Age: 68","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1967","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333773/suppl/GSM333773.txt.gz","41000","68","AD114","dataset II","Mut","N","AD","Wt","Wt","F","","0","IA","Alive","1967","T1N0M0"
"GSM333774","Patient 115 with adenocarcinoma","GSM333774","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD115","Cohort: dataset II","Age: 72","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 2041","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333774/suppl/GSM333774.txt.gz","41000","72","AD115","dataset II","Mut","N","AD","Wt","Mut","F","","0","IA","Alive","2041","T1N0M0"
"GSM333775","Patient 116 with adenocarcinoma","GSM333775","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD116","Cohort: dataset II","Age: 63","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1042","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333775/suppl/GSM333775.txt.gz","41000","63","AD116","dataset II","Mut","Y","AD","Wt","Wt","F","PM","0","IA","Dead","1042","T1N0M0"
"GSM333776","Patient 117 with adenocarcinoma","GSM333776","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD117","Cohort: dataset II","Age: 35","Sex: M","Histology: AD","Smoking (BI): 1020","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1994","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333776/suppl/GSM333776.txt.gz","41000","35","AD117","dataset II","Wt","N","AD","Wt","Wt","M","","1020","IA","Alive","1994","T1N0M0"
"GSM333777","Patient 118 with adenocarcinoma","GSM333777","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD118","Cohort: dataset II","Age: 59","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1618","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333777/suppl/GSM333777.txt.gz","41000","59","AD118","dataset II","Mut","N","AD","Wt","Mut","F","","0","IB","Dead","1618","T2N0M0"
"GSM333778","Patient 119 with adenocarcinoma","GSM333778","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD119","Cohort: dataset II","Age: 65","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1849","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333778/suppl/GSM333778.txt.gz","41000","65","AD119","dataset II","Mut","N","AD","Wt","Wt","F","","0","IA","Alive","1849","T1N0M0"
"GSM333779","Patient 120 with adenocarcinoma","GSM333779","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD120","Cohort: dataset II","Age: 47","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1823","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333779/suppl/GSM333779.txt.gz","41000","47","AD120","dataset II","Wt","N","AD","Mut","Wt","F","","0","IB","Alive","1823","T2N0M0"
"GSM333780","Patient 121 with adenocarcinoma","GSM333780","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD121","Cohort: dataset II","Age: 61","Sex: M","Histology: AD","Smoking (BI): 1050","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1836","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333780/suppl/GSM333780.txt.gz","41000","61","AD121","dataset II","Wt","N","AD","Wt","Mut","M","","1050","IB","Alive","1836","T2N0M0"
"GSM333781","Patient 122 with adenocarcinoma","GSM333781","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD122","Cohort: dataset II","Age: 76","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1931","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333781/suppl/GSM333781.txt.gz","41000","76","AD122","dataset II","Wt","N","AD","Wt","Wt","F","","0","IB","Alive","1931","T2N0M0"
"GSM333782","Patient 123 with adenocarcinoma","GSM333782","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD123","Cohort: dataset II","Age: 48","Sex: F","Histology: AD","Smoking (BI): 840","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1843","Evidence of relapse: N","Site of relapse:","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333782/suppl/GSM333782.txt.gz","41000","48","AD123","dataset II","Mut","N","AD","Wt","Wt","F","","840","IB","Alive","1843","T2N0M0"
"GSM333783","Patient 124 with adenocarcinoma","GSM333783","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD124","Cohort: dataset II","Age: 57","Sex: M","Histology: AD","Smoking (BI): 400","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1852","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333783/suppl/GSM333783.txt.gz","41000","57","AD124","dataset II","Wt","N","AD","Wt","Wt","M","","400","IA","Alive","1852","T1N0M0"
"GSM333784","Patient 125 with adenocarcinoma","GSM333784","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD125","Cohort: dataset II","Age: 60","Sex: F","Histology: AD","Smoking (BI): 0","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1907","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333784/suppl/GSM333784.txt.gz","41000","60","AD125","dataset II","Mut","Y","AD","Wt","Wt","F","PM","0","IA","Alive","1907","T1N0M0"
"GSM333785","Patient 126 with adenocarcinoma","GSM333785","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD126","Cohort: dataset II","Age: 47","Sex: M","Histology: AD","Smoking (BI): 320","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 713","Evidence of relapse: Y","Site of relapse: Brain","EGFR status: Wt","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333785/suppl/GSM333785.txt.gz","41000","47","AD126","dataset II","Wt","Y","AD","Wt","Mut","M","Brain","320","IA","Dead","713","T1N0M0"
"GSM333786","Patient 127 with adenocarcinoma","GSM333786","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD127","Cohort: dataset II","Age: 35","Sex: M","Histology: AD","Smoking (BI): 210","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Alive","Survival (days): 1858","Evidence of relapse: N","Site of relapse:","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333786/suppl/GSM333786.txt.gz","41000","35","AD127","dataset II","Wt","N","AD","Wt","Wt","M","","210","IA","Alive","1858","T1N0M0"
"GSM333787","Patient 128 with adenocarcinoma","GSM333787","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD128","Cohort: dataset II","Age: 49","Sex: F","Histology: AD","Smoking (BI): 220","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Alive","Survival (days): 1696","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Mut","K-ras Status: Wt","p53 Status: Mut","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333787/suppl/GSM333787.txt.gz","41000","49","AD128","dataset II","Mut","Y","AD","Wt","Mut","F","PM","220","IB","Alive","1696","T2N0M0"
"GSM333788","Patient 129 with adenocarcinoma","GSM333788","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD129","Cohort: dataset II","Age: 61","Sex: M","Histology: AD","Smoking (BI): 700","TNM (Pathological): T1N0M0","Stage (Pathological ): IA","Status: Dead","Survival (days): 1252","Evidence of relapse: Y","Site of relapse: PM","EGFR status: Wt","K-ras Status: Wt","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333788/suppl/GSM333788.txt.gz","41000","61","AD129","dataset II","Wt","Y","AD","Wt","Wt","M","PM","700","IA","Dead","1252","T1N0M0"
"GSM333789","Patient 130 with adenocarcinoma","GSM333789","Public on Jun 23 2009","Oct 15 2008","Jun 23 2009","RNA","2","Primary lung tumor","Homo sapiens","Annotation: AD130","Cohort: dataset II","Age: 61","Sex: M","Histology: AD","Smoking (BI): 800","TNM (Pathological): T2N0M0","Stage (Pathological ): IB","Status: Dead","Survival (days): 1222","Evidence of relapse: Y","Site of relapse: Derm (skin), med LN, bone","EGFR status: Wt","K-ras Status: Mut","p53 Status: Wt","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy5","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","Total RNA from 20 lung cell lines representing all major histological types of lung cancers, labeled with Cyanine-3 (green).","Homo sapiens","n/a","total RNA","Total RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA), followed by treatment with DNase I. Double-stranded cDNA was synthesized from 500 ng of total RNA using MMLV-RT and poly dT primer incorporating the T7 promoter.","Cy3","cRNA was generated and labeled with Cy3 or Cy5 (CyDye, Amersham Pharmacia Biotech, Piscataway, NJ) using the Low RNA Fluorescen","9606","standard Affymetrix protocol","Whole Human Genome oligo DNA microarray with 41000 distinct probes was scanned using an Agilent DNA microarray scanner (G2505B, Agilent Technologies). Images were quantified using Agilent Feature Extraction Software (version 9.5).","dataset II","LOWESS normalized, background subtracted VALUE data obtained from ratio of processed Red signal/processed Green signal using GeneSpring software.","GPL6480","Takashi,,Takahashi","Aichi Cancer Center","1-1 Kanokoden, Chikusa-ku","Nagoya","Aichi","464-8681","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM333nnn/GSM333789/suppl/GSM333789.txt.gz","41000","61","AD130","dataset II","Wt","Y","AD","Mut","Wt","M","Derm (skin), med LN, bone","800","IB","Dead","1222","T2N0M0"
